Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly and Co.
Looking at options history for Eli Lilly and Co LLY we detected 22 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $274,900 and 19, calls, for a total amount of $1,883,987.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $450.0 to $1000.0 for Eli Lilly and Co over the recent three months.
Volume & Open Interest Trends
In today's trading context, the average open interest for options of Eli Lilly and Co stands at 599.84, with a total volume reaching 875.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Eli Lilly and Co, situated within the strike price corridor from $450.0 to $1000.0, throughout the last 30 days.
Eli Lilly and Co 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BULLISH | 08/16/24 | $134.05 | $133.25 | $134.05 | $710.00 | $670.2K | 372 | 100 |
| LLY | CALL | TRADE | BULLISH | 08/16/24 | $133.5 | $131.25 | $133.5 | $710.00 | $200.2K | 372 | 150 |
| LLY | CALL | TRADE | BEARISH | 01/17/25 | $119.2 | $117.0 | $117.0 | $780.00 | $198.9K | 3.8K | 6 |
| LLY | CALL | TRADE | NEUTRAL | 08/16/24 | $44.9 | $41.5 | $43.3 | $840.00 | $129.9K | 564 | 31 |
| LLY | PUT | SWEEP | BEARISH | 10/18/24 | $12.0 | $11.3 | $12.0 | $700.00 | $103.2K | 373 | 161 |
About Eli Lilly and Co
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Having examined the options trading patterns of Eli Lilly and Co, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Eli Lilly and Co's Current Market Status
- With a trading volume of 277,995, the price of LLY is up by 0.82%, reaching $827.04.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 64 days from now.
What The Experts Say On Eli Lilly and Co
In the last month, 1 experts released ratings on this stock with an average target price of $840.0.
- An analyst from Argus Research has decided to maintain their Buy rating on Eli Lilly and Co, which currently sits at a price target of $840.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly and Co, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
